(Q41657844)

English

Bispecific Antibody-directed Antitumor Activity of Human CD4+Helper/Killer T Cells Induced by Anti-CD3 Monoclonal Antibody plus Interleukin 2

scientific article published on November 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

Bispecific Antibody-directed Antitumor Activity of Human CD4+Helper/Killer T Cells Induced by Anti-CD3 Monoclonal Antibody plus Interleukin 2 (English)

reason for preferred rank

most precise value

1 reference

10.1111/J.1349-7006.1991.TB01782.X

https://api.crossref.org/works/10.1111/J.1349-7006.1991.TB01782.X

6 December 2022

Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

immunologic cytotoxicity

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

1 reference

10.1111/J.1349-7006.1991.TB01782.X

https://api.crossref.org/works/10.1111/J.1349-7006.1991.TB01782.X

6 December 2022

author name string

T. Nishimura

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

Y. Nakamura

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

Y. Takeuchi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

X. H. Gao

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

Y. Tokuda

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

K. Okumura

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

S. Habu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1836455

6 December 2022

publication date

1 November 1991

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

number of pages

4

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://europepmc.org/articles/PMC5918327

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

https://europepmc.org/articles/PMC5918327?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836455

6 December 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.1991.tb01782.x

1 reference

10.1111/J.1349-7006.1991.TB01782.X

https://api.crossref.org/works/10.1111/J.1349-7006.1991.TB01782.X

6 December 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1991.tb01782.x/fullpdf

1 reference

10.1111/J.1349-7006.1991.TB01782.X

https://api.crossref.org/works/10.1111/J.1349-7006.1991.TB01782.X

6 December 2022

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

82

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

11

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

1207-1210

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Use of Millipore diffusion chambers to assay in vivo IL-2 activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Induction of cytotoxicity in human T cells coated with anti-glioma x anti-CD3 bispecific antibody against human glioma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Preliminary trial of specific targeting therapy against malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Macrophage-T cell interaction is essential for the induction of p75 interleukin 2 (IL-2) receptor and IL-2 responsiveness in human CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

30 June 2018

Surface markers of cloned human T cells with various cytolytic activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918327

18 August 2018

Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1991.TB01782.X

21 January 2018

Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3

1 reference

https://pubmed.ncbi.nlm.nih.gov/1836455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1836455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of slowly released recombinant interleukin 2. Augmentation of the efficacy of adoptive immunotherapy with lymphokine-activated killer (LAK) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1836455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1836455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinction between antigen receptor and IL 2 receptor triggering events in the activation of alloreactive T cell clones with calcium ionophore and phorbol ester

1 reference

https://pubmed.ncbi.nlm.nih.gov/1836455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential requirements for activation and growth of unprimed cytotoxic and helper T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1836455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/1836455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.1991.TB01782.X

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5918327

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41657844&oldid=1785406177"